1. Home
  2. FORA vs BTMD Comparison

FORA vs BTMD Comparison

Compare FORA & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forian Inc.

FORA

Forian Inc.

HOLD

Current Price

$2.16

Market Cap

67.3M

Sector

Technology

ML Signal

HOLD

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.17

Market Cap

72.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORA
BTMD
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.3M
72.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
FORA
BTMD
Price
$2.16
$2.17
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.83
AVG Volume (30 Days)
39.5K
199.3K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
25.00
722.22
EPS
N/A
0.74
Revenue
$30,256,919.00
$192,219,000.00
Revenue This Year
$8.44
$2.03
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
$2.84
Revenue Growth
50.13
N/A
52 Week Low
$1.64
$1.27
52 Week High
$2.71
$4.75

Technical Indicators

Market Signals
Indicator
FORA
BTMD
Relative Strength Index (RSI) 60.16 58.16
Support Level $2.11 $2.02
Resistance Level $2.20 $2.20
Average True Range (ATR) 0.01 0.12
MACD -0.00 -0.02
Stochastic Oscillator 33.33 54.15

Price Performance

Historical Comparison
FORA
BTMD

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Share on Social Networks: